PE107899A1 - PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS - Google Patents
PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORSInfo
- Publication number
- PE107899A1 PE107899A1 PE1998000828A PE00082898A PE107899A1 PE 107899 A1 PE107899 A1 PE 107899A1 PE 1998000828 A PE1998000828 A PE 1998000828A PE 00082898 A PE00082898 A PE 00082898A PE 107899 A1 PE107899 A1 PE 107899A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- compound
- pirrolopyrolone
- leucocitary
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, R1 ES ALQUILO C1-C6; R2 ES ALQUILO C2-C4 o ALQUENILO C2-C4; X ES CO o SO2; HET ES UN MONOCICLO O BICICLO AROMATICO DE 5-10 MIEMBROS OPCIONALMENTE SUSTITUIDO; n ES 0-4; R3 Y R4 SON H, ALQUILO C1-C8, -(CH2)(1-4)CONR5R6, CO(ALQUILO C1-C4), (CH2)(CERO-2)Fen; Fen ES FENILO OPCIONALMENTE SUSTITUIDO; O NR3R4 SON AZETIDINILO, PIRROLIDINILO, PIPERIDINILO,ENTRE OTROS; R5 Y R6 SON H o ALQUILO C1-C4. UN COMPUESTO PREFERIDO ES (3S,3aS,6aR)-3-ISOPROPIL-1-METANSULFONIL-4-(2-PIRROLIDIN-1-ILMETIL-OXAZOL-4-CARBONIL)-HEXAHIDRO-PIRROLO[3,2-b]PIRROL-2-ONA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHIBIDOR DE LA ELASTASA NEUTROFILA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE BRONQUITIS CRONICA O ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, ASMAIT REFERS TO A COMPOUND OF FORMULA I, R1 IS C1-C6 ALKYL; R2 IS C2-C4 ALKYL or C2-C4 ALKYNYL; X IS CO or SO2; HET IS AN OPTIONALLY REPLACED 5-10 MEMBER AROMATIC MONOCYCLE OR BICYCLE; n ES 0-4; R3 and R4 ARE H, C1-C8 ALKYL, - (CH2) (1-4) CONR5R6, CO (C1-C4 ALKYL), (CH2) (ZERO-2) Fen; Fen is optionally substituted phenyl; OR NR3R4 ARE AZETIDINYL, PYRROLIDINYL, PIPERIDINYL, AMONG OTHERS; R5 AND R6 ARE H or C1-C4 ALKYL. A PREFERRED COMPOUND IS (3S, 3aS, 6aR) -3-ISOPROPIL-1-METANSULFONIL-4- (2-PIRROLIDIN-1-ILMETIL-OXAZOL-4-CARBONIL) -HEXAHIDRO-PIRROLO [3,2-b] PIRROL- 2-ONA; AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I IS A NEUTROPHILIC ELASTASE INHIBITOR AND MAY BE USEFUL FOR THE TREATMENT OF CHRONIC BRONCHITIS OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9719189.4A GB9719189D0 (en) | 1997-09-09 | 1997-09-09 | New therapeutic method |
| GBGB9719183.7A GB9719183D0 (en) | 1997-09-09 | 1997-09-09 | Compounds |
| GBGB9719290.0A GB9719290D0 (en) | 1997-09-10 | 1997-09-10 | Compounds |
| GBGB9803611.4A GB9803611D0 (en) | 1998-02-21 | 1998-02-21 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE107899A1 true PE107899A1 (en) | 1999-11-17 |
Family
ID=27451698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000828A PE107899A1 (en) | 1997-09-09 | 1998-09-04 | PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1003748A2 (en) |
| JP (1) | JP2001515904A (en) |
| KR (1) | KR20010023766A (en) |
| CN (1) | CN1278820A (en) |
| AP (1) | AP2000001761A0 (en) |
| AR (1) | AR017072A1 (en) |
| AU (1) | AU9741298A (en) |
| BR (1) | BR9812062A (en) |
| CA (1) | CA2303176A1 (en) |
| CO (1) | CO4970719A1 (en) |
| EA (1) | EA200000204A1 (en) |
| EE (1) | EE200000138A (en) |
| HU (1) | HUP0004644A3 (en) |
| ID (1) | ID24452A (en) |
| IL (1) | IL134791A0 (en) |
| IS (1) | IS5391A (en) |
| MA (1) | MA26543A1 (en) |
| NO (1) | NO20001198L (en) |
| NZ (1) | NZ503130A (en) |
| PE (1) | PE107899A1 (en) |
| PL (1) | PL339176A1 (en) |
| SK (1) | SK3192000A3 (en) |
| TR (1) | TR200000907T2 (en) |
| WO (1) | WO1999012933A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905418D0 (en) * | 1999-03-09 | 1999-05-05 | Glaxo Group Ltd | Process |
| EP1771432B1 (en) | 2004-03-31 | 2010-12-08 | Janssen Pharmaceutica NV | Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| DE102004024772A1 (en) * | 2004-05-17 | 2005-12-22 | Grünenthal GmbH | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| TWI355380B (en) * | 2004-05-27 | 2012-01-01 | Nihon Nohyaku Co Ltd | Substituted pyrazinecarboxanilide derivatives or s |
| JP4853759B2 (en) * | 2004-05-27 | 2012-01-11 | 日本農薬株式会社 | Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates thereof, agricultural and horticultural agents, and methods of use thereof |
| GB2418427A (en) | 2004-09-02 | 2006-03-29 | Univ Cambridge Tech | Ligands for G-protein coupled receptors |
| CA2590533C (en) | 2004-11-23 | 2010-09-07 | Warner-Lambert Company Llc | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| EP2024367B1 (en) | 2006-05-04 | 2010-09-08 | Pulmagen Therapeutics (Inflammation) Limited | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| US8198288B2 (en) | 2006-05-04 | 2012-06-12 | Pulmagen Therapeutics (Inflammation) Limited | Tetrahydropyrrolopyrimidinediones and their use in therapy |
| GB2452696B (en) | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
| US7662967B2 (en) | 2007-08-02 | 2010-02-16 | Cambridge Enterprise Limited | Anti-inflammatory compounds and compositions |
| WO2009060206A1 (en) * | 2007-11-07 | 2009-05-14 | Argenta Discovery Limited | 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
| US20110212181A1 (en) * | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
| AU2020349353A1 (en) | 2019-09-17 | 2022-04-14 | Duke University | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
| AU2021256835A1 (en) | 2020-04-16 | 2022-10-13 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
| EP4419102A1 (en) | 2021-10-20 | 2024-08-28 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
| GB9402680D0 (en) * | 1994-02-11 | 1994-04-06 | Zeneca Ltd | Pyrrolidine derivatives |
| AP823A (en) * | 1996-03-28 | 2000-04-25 | Glaxo Group Ltd | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. |
-
1998
- 1998-09-04 PE PE1998000828A patent/PE107899A1/en not_active Application Discontinuation
- 1998-09-07 PL PL98339176A patent/PL339176A1/en not_active Application Discontinuation
- 1998-09-07 KR KR1020007002422A patent/KR20010023766A/en not_active Application Discontinuation
- 1998-09-07 ID IDW20000445A patent/ID24452A/en unknown
- 1998-09-07 BR BR9812062-0A patent/BR9812062A/en not_active Application Discontinuation
- 1998-09-07 JP JP2000510740A patent/JP2001515904A/en active Pending
- 1998-09-07 AR ARP980104458A patent/AR017072A1/en unknown
- 1998-09-07 NZ NZ503130A patent/NZ503130A/en unknown
- 1998-09-07 AU AU97412/98A patent/AU9741298A/en not_active Abandoned
- 1998-09-07 SK SK319-2000A patent/SK3192000A3/en unknown
- 1998-09-07 EA EA200000204A patent/EA200000204A1/en unknown
- 1998-09-07 TR TR2000/00907T patent/TR200000907T2/en unknown
- 1998-09-07 CA CA002303176A patent/CA2303176A1/en not_active Abandoned
- 1998-09-07 MA MA25243A patent/MA26543A1/en unknown
- 1998-09-07 IL IL13479198A patent/IL134791A0/en unknown
- 1998-09-07 CN CN98810954A patent/CN1278820A/en active Pending
- 1998-09-07 AP APAP/P/2000/001761A patent/AP2000001761A0/en unknown
- 1998-09-07 WO PCT/EP1998/005609 patent/WO1999012933A2/en not_active Application Discontinuation
- 1998-09-07 HU HU0004644A patent/HUP0004644A3/en unknown
- 1998-09-07 EP EP98951348A patent/EP1003748A2/en not_active Withdrawn
- 1998-09-07 EE EEP200000138A patent/EE200000138A/en unknown
- 1998-09-08 CO CO98051488A patent/CO4970719A1/en unknown
-
2000
- 2000-02-29 IS IS5391A patent/IS5391A/en unknown
- 2000-03-08 NO NO20001198A patent/NO20001198L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU9741298A (en) | 1999-03-29 |
| ID24452A (en) | 2000-07-20 |
| NO20001198L (en) | 2000-05-08 |
| WO1999012933A2 (en) | 1999-03-18 |
| CA2303176A1 (en) | 1999-03-18 |
| TR200000907T2 (en) | 2000-11-21 |
| AP2000001761A0 (en) | 2000-03-31 |
| NO20001198D0 (en) | 2000-03-08 |
| MA26543A1 (en) | 2004-12-20 |
| EA200000204A1 (en) | 2000-10-30 |
| AR017072A1 (en) | 2001-08-22 |
| NZ503130A (en) | 2001-08-31 |
| CO4970719A1 (en) | 2000-11-07 |
| IL134791A0 (en) | 2001-04-30 |
| KR20010023766A (en) | 2001-03-26 |
| HUP0004644A3 (en) | 2002-01-28 |
| HUP0004644A2 (en) | 2001-09-28 |
| BR9812062A (en) | 2000-09-26 |
| CN1278820A (en) | 2001-01-03 |
| SK3192000A3 (en) | 2001-03-12 |
| WO1999012933A3 (en) | 1999-05-27 |
| PL339176A1 (en) | 2000-12-04 |
| IS5391A (en) | 2000-02-29 |
| EE200000138A (en) | 2001-02-15 |
| JP2001515904A (en) | 2001-09-25 |
| EP1003748A2 (en) | 2000-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE107899A1 (en) | PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS | |
| EA200100755A1 (en) | 4-OXO-1,4-DIHYDRO-3-QUINOLINKARBOXAMIDES AS ANTI-VIRUS AGENTS | |
| DE60019317D1 (en) | quinazoline derivatives | |
| DK0388948T3 (en) | Acryloyl-substituted pyrrole derivatives | |
| DE60307179D1 (en) | UV radiation protective compositions | |
| AU6645998A (en) | Oxygen or sulfur containing heteroaromatics as factor xa inhibitors | |
| PH23979A (en) | 2,3-dihydroxy-quinolines and pharmaceutical composition containing them | |
| DK1401837T3 (en) | Purine derivatives as A2B adenosine receptor antagonists | |
| NO992259L (en) | New use for 1,3-propanediol derivatives | |
| AU3015289A (en) | 2'-deoxy-5-fluorouridine derivatives | |
| DK0790987T3 (en) | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors | |
| HK1048303A1 (en) | Aminobenzophenoses as inhibitors of il-1b and tnf -a. | |
| EA200100516A1 (en) | DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE | |
| MX9400901A (en) | MICROBICIDES | |
| WO2002014456A3 (en) | Use of trioxepans in ignition improved fuels | |
| HUP0001311A2 (en) | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |